phenytoin
Generic: phenytoin
Labeler: sun pharmaceutical industries, inc.Drug Facts
Product Profile
Brand Name
phenytoin
Generic Name
phenytoin
Labeler
sun pharmaceutical industries, inc.
Dosage Form
SUSPENSION
Routes
Active Ingredients
phenytoin 125 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
51672-4069
Product ID
51672-4069_3cbd8a0c-6cfb-e0dd-e063-6394a90a8a26
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA040521
Listing Expiration
2026-12-31
Marketing Start
2004-04-08
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
516724069
Hyphenated Format
51672-4069
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
phenytoin (source: ndc)
Generic Name
phenytoin (source: ndc)
Application Number
ANDA040521 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 125 mg/5mL
Packaging
- 237 mL in 1 BOTTLE (51672-4069-1)
- 1 BOTTLE in 1 CARTON (51672-4069-2) / 237 mL in 1 BOTTLE
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3cbd8a0c-6cfb-e0dd-e063-6394a90a8a26", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000191266", "N0000187064", "N0000187063", "N0000185607", "N0000191267", "N0000190118", "N0000185507"], "upc": ["0351672406929"], "unii": ["6158TKW0C5"], "rxcui": ["1313112"], "spl_set_id": ["093fd736-5971-47af-b4ef-08c1696cebe8"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_moa": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "237 mL in 1 BOTTLE (51672-4069-1)", "package_ndc": "51672-4069-1", "marketing_end_date": "20260731", "marketing_start_date": "20040408"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (51672-4069-2) / 237 mL in 1 BOTTLE", "package_ndc": "51672-4069-2", "marketing_start_date": "20250723"}], "brand_name": "Phenytoin", "product_id": "51672-4069_3cbd8a0c-6cfb-e0dd-e063-6394a90a8a26", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51672-4069", "generic_name": "Phenytoin", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phenytoin", "active_ingredients": [{"name": "PHENYTOIN", "strength": "125 mg/5mL"}], "application_number": "ANDA040521", "marketing_category": "ANDA", "marketing_start_date": "20040408", "listing_expiration_date": "20261231"}